XML 54 R44.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]      
Incentive stock options, granted 3,245,000 900,000  
Options granted, exercise price, per share $ 0.50 $ 0.36  
Stock options, exercised 950,000 625,000  
Stock-based compensation expense $ 257,557 $ 692,138  
Deferred compensation expense $ 1,771,133    
Incentive Stock      
Defined Benefit Plan Disclosure [Line Items]      
Incentive stock options, granted 3,245,000 900,000  
Incentive stock options, grant, additional information Each independent Board member was granted 25,000 shares in the first and second quarter of 2023, for a total of 50,000 shares each. Three (3) key employees were granted a total of 2,050,000 share options. An independent member of the Board of Directors was granted 750,000 share options, and a total of 345,000 share options were granted among nine (9) employees. During the year ended December 31, 2023, 200,000 shares were exercised by two (2) independent members of the Board of Directors. During the year ended 2023, 700,000 partially vested share options were forfeited by two (2) key employees of the Company. The Aggregate Intrinsic Value is based on the market value of the Company’s common stock of $0.89 on December 31, 2023. Each independent Board member was granted 25,000 shares per quarter of service in 2022, for a total of 100,000 shares each. The key employees were granted 700,000 share options as part of their employment agreements. During the year ended December 31, 2022, 625,000 shares were exercised by three (3) former employees of the Company, who received these options as part of their employment agreements. During 2022, 130,000 share options were forfeited, of which 50,000 options were forfeited by an independent consultant, and 80,000 options were forfeited by two (2) former employees of the Company. The Aggregate Intrinsic Value is based on the market value of the Company’s common stock of $1.10 on December 31, 2022.  
Sole Shareholder      
Defined Benefit Plan Disclosure [Line Items]      
Shares issued, acqusition     13,500,000
Incentive stock options, granted     1,500,000
Options granted, exercise price, per share     $ 0.22
Chief Executive Officer      
Defined Benefit Plan Disclosure [Line Items]      
Stock options, exercised 750,000    
Shares issued as a result of options exercised 750,000    
Stock price $ 0.22